Delivery Order SPE2DU25D4211-SPE2DU26FB986

On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $8,555.21 to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued without a set-aside designation, represents a task order executed under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999.999 billion through December 2026. The contract supports federal medical procurement requirements, particularly for military and veteran healthcare systems, with the work to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania.

AmerSourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for the DLA's medical supply chain, delivering a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The parent company, Cencora, Inc., holds the primary $999.999 billion IDC with DLA Troop Support Medical through December 2031, positioning it as a key supplier for military treatment facilities and federal healthcare institutions globally. All of the company's federal contract awards, including this delivery order, have been competitively awarded on a full and open basis without set-aside restrictions, demonstrating AmerSourceBergen's capability to compete effectively for federal medical procurement requirements.